on behalf of the MADIT-CRT Executive CommitteeBackground-We hypothesized that combined assessment of factors that are associated with favorable reverse remodeling after cardiac resynchronization-defibrillator therapy (CRT-D) can be used to predict clinical response to the device. Methods and Results-The study population comprised 1761 patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT). Best-subset regression analysis was performed to identify factors associated with echocardiographic response (defined as percent reduction in left ventricular end-diastolic volume 1 year after CRT-D implantation) and to create a response score. Cox proportional hazards regression analysis was used to evaluate the CRT-D versus defibrillator-only reduction in the risk of heart failure or death by the response score. Seven factors were identified as associated with echocardiographic response to CRT-D and made up the response score (female sex, nonischemic origin, left bundle-branch block, QRS Ն150 milliseconds, prior hospitalization for heart failure, left ventricular end-diastolic volume Ն125 mL/m 2 , and left atrial volume Ͻ40 mL/m 2 ). Multivariate analysis showed a 13% (PϽ0.001) increase in the clinical benefit of CRT-D per 1-point increment in the response score (range, 0 -14) and a significant direct correlation between risk reduction associated with CRT-D and response score quartiles: Patients in the first quartile did not derive a significant reduction in the risk of heart failure or death with CRT-D (hazard ratioϭ0.87; Pϭ0.52); patients in the second and third quartiles derived 33% (Pϭ0.04) and 36% (Pϭ0.03) risk reductions, respectively; and patients in the upper quartile experienced a 69% (PϽ0.001) risk reduction (P for trendϭ0.005). Conclusion-Combined assessment of factors associated with reverse remodeling can be used for improved selection of patients for cardiac resynchronization therapy. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00180271.